Sandra J. Gunselman
Amministratore Delegato presso Mobility Health, Inc.
Profilo
Sandra J.
Gunselman is the founder and current President & Chief Executive Officer of Mobility Health, Inc. which is founded in 2020.
She is also currently the Vice President-Laboratory Operations at Assurex Health, Inc. where she started in 2015.
Dr. Gunselman holds a doctorate degree from Colorado State University and an undergraduate degree from Lipscomb University.
Posizioni attive di Sandra J. Gunselman
| Società | Posizione | Inizio |
|---|---|---|
Assurex Health, Inc.
 Assurex Health, Inc. Pharmaceuticals: MajorHealth Technology AssureRx Health, Inc. operates as a personalized medicine company that develops genetic tests. It specializes in pharmacogenomics, a study of the genetic factors that influence an individual’s response to drug treatments, as well as evidence-based medicine and clinical pharmacology. The firm offers GeneSight, a genetic test that helps healthcare providers to take a personalized approach for prescribing medicine for patients; GeneSight Psychotropic, a test that analyzes genes that affects a patient’s response to antidepressant and antipsychotic medications; and GeneSight Analgesic, a test that analyzes how genes affect the way the body respond to medicines prescribed to treat acute or chronic pain. The company was founded by Donald R. Wright Jr. in 2006 and is headquartered in Mason, OH. | Corporate Officer/Principal | 29/06/2015 |
| Mobility Health, Inc. | Amministratore Delegato | 01/01/2020 |
Formazione di Sandra J. Gunselman
| Lipscomb University | Undergraduate Degree |
| Colorado State University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Assurex Health, Inc.
Assurex Health, Inc. Pharmaceuticals: MajorHealth Technology AssureRx Health, Inc. operates as a personalized medicine company that develops genetic tests. It specializes in pharmacogenomics, a study of the genetic factors that influence an individual’s response to drug treatments, as well as evidence-based medicine and clinical pharmacology. The firm offers GeneSight, a genetic test that helps healthcare providers to take a personalized approach for prescribing medicine for patients; GeneSight Psychotropic, a test that analyzes genes that affects a patient’s response to antidepressant and antipsychotic medications; and GeneSight Analgesic, a test that analyzes how genes affect the way the body respond to medicines prescribed to treat acute or chronic pain. The company was founded by Donald R. Wright Jr. in 2006 and is headquartered in Mason, OH. | Health Technology |
| Mobility Health, Inc. |
- Borsa valori
- Insiders
- Sandra J. Gunselman
